InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Simonian Nancy A, Chairman & CEO. Insider active across 2 companies, notably Seagen Inc.. Cumulatively, 5 disclosures have been published. The latest transaction was disclosed on 13 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
01,503 shares0
Common Stock
SEC:0000899243-22-018458:0·
€59,56258,883 shares@ €1.0115100.0% of flow
Common Stock
SEC:0001209191-22-022499:0·
€450,02325,000 shares@ €18.0009100.0% of flow
Common Stock
SEC:0000899243-22-009424:0·
01,402 shares0
Common Stock
SEC:0001203311-21-000036·
01,402 shares0
Common Stock
SEC:0001203311-21-000036:0·
5 of 5 declarations
About Simonian Nancy A
Nancy A. Simonian is the President and CEO of Seagen Inc. and Syros Pharmaceuticals, Inc. She leads both companies with a vision focused on innovation and research. Her leadership is essential for achieving the strategic and operational objectives of these organizations.
